DONG HA, Vietnam, 26 février 2024 /PRNewswire/ — Electric Wind Power (« l’entreprise », SHA:688660), une filiale de Shanghai Electric (SEHK:2727, SSE:601727), également le premier fabricant chinois d’équipements éoliens terrestres et l’un des plus grands fabricants chinois d’équipements…
Month: February 2024
LOS ANGELES, Feb. 26, 2024 /PRNewswire/ — B. Riley Securities, a leading middle market brokerage and investment bank, and subsidiary of B. Riley Financial (Nasdaq: RILY) (“B. Riley”), today announced that it will host a Radiopharma Investor Conference on March 1, 2024 in New York. This…
LOS ANGELES, Feb. 26, 2024 /PRNewswire/ — B. Riley Securities, a leading middle market brokerage and investment bank, and subsidiary of B. Riley Financial (Nasdaq: RILY) (“B. Riley”), today announced that it will host a Radiopharma Investor Conference on March 1, 2024 in New York. This…
Adding OCTEON® 10 processor to Linux Foundation’s Datapath Developer Kit and the Apache device library provides ML model developers standardized API access to the chip’s ML/AI acceleration engine. Improves the performance of 5G RAN networks by enabling OEMs and operators, such as Nokia…
Adding OCTEON® 10 processor to Linux Foundation’s Datapath Developer Kit and the Apache device library provides ML model developers standardized API access to the chip’s ML/AI acceleration engine. Improves the performance of 5G RAN networks by enabling OEMs and operators, such as Nokia…
– Active relapsed or refractory AML patients 65+ years receiving an Iomab-B led Bone Marrow Transplant (BMT) achieved significant improvement in survival at one and two years compared to control arm patients none of whom survived even one year – Unprecedented 100% BMT access and…
– Active relapsed or refractory AML patients 65+ years receiving an Iomab-B led Bone Marrow Transplant (BMT) achieved significant improvement in survival at one and two years compared to control arm patients none of whom survived even one year – Unprecedented 100% BMT access and…
WEST SACRAMENTO, Calif., Feb. 26, 2024 /PRNewswire/ — Gemini Bioproducts, LLC (“GeminiBio”), a leading supplier of cell culture reagents and process liquids, a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, today…
WEST SACRAMENTO, Calif., Feb. 26, 2024 /PRNewswire/ — Gemini Bioproducts, LLC (“GeminiBio”), a leading supplier of cell culture reagents and process liquids, a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, today…
WALTHAM, Mass., Feb. 26, 2024 /PRNewswire/ — Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment…